The Detrimental Impact of Tech Debt in Healthcare and Life Sciences
With increased transaction activity and consolidations in the evolving healthcare industry, mergers and acquisitions (M&A) stakeholders struggle to navigate M&A deals amid the pressures of complex regulations and nuanced markets. The Crowe team of M&A professionals can help.
The Crowe team of M&A specialists combines functional expertise and best practices with years of healthcare industry knowledge to help you assess and identify your organization’s strengths, weaknesses, and strategies for success before you begin the process.
Our focused and flexible approach to due diligence can help you analyze value and detect weaknesses and strengths in your financials, operations, people and culture. We can help you investigate assets, liabilities, capabilities, processes, and technologies. Our team can offer insight to help you meet the timing, scope, and deliverables that are unique to each transaction.
Whether you are considering an acquisition or divestiture, in the midst of contractual arrangements, or undergoing financial transactions with physicians, Crowe offers objective analysis, industry insight, and broad technical knowledge for your valuation.
The Detrimental Impact of Tech Debt in Healthcare and Life Sciences
Unlocking Value: Cybersecurity in Life Sciences and Healthcare
Children’s Hospital Webinar Series: Event Recordings
Preparing for a Financial Statement Audit in Healthcare
What Bad-Debt Expense Analysis Tells Charitable Hospitals
Set your organization up for M&A success with a team of professionals who understand specific healthcare industry challenges.